Investigative teams at Universitá Degli Studi di Torino (UNITO), Ruprecht Karls-Universitaet Heidelberg (UHEI) and RCSI, the Royal College of Surgeons in Ireland have recently published two COLOSSUS-acknowledged studies. Congratulations to all researchers involved!
The first study by Irene Catalano and Livio Trusolino at UNITO, The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR Therapy was published in the July 8, 2019 edition of Cancer Cell, Volume 36, Issue 1, 8 July 2019, Pages 1-3, DOI: 10.1016/j.ccell.2019.06.001.
The second study, Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A by Elke Burgermeister, Francesca Battaglin, Fagr Eladly, Wen Wu, Frank Herweck , Nadine Schulte, Johannes Betge, Nicolai Härtel, Jakob N. Kather, Cleo-Aron Weis, Timo Gaiser, Alexander Marx, Christel Weiss, Ralf Hofheinz, Ian S. Miller, Fotios Loupakis, Heinz-Josef Lenz, Annette T. Byrne, Matthias P. Ebert appeared in the July 9, 2019 issue of EBioMedicine; 45:139-154. DOI: 10.1016/j.ebiom.2019.07.004.
Learn more about COLOSSUS on the project website www.colossusproject.eu
COLOSSUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 754923. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.